Therapeutic Potential of Epigallocatechin Gallate Nanodelivery Systems

Table 2

Liposomes used as EGCG carriers. Note. N/A denotes “not available” data.

Particle	Loading capacity; (%)	Loading efficiency; (%)	Size (nm)	Administration route	In vitro/in vivo results	Ref.
Egg lecithin and cholesterol	N/A	45–78	89–93	Topical	Enhanced anti-MRSA activity in vitro and in vivo	[33]
PhC and cholesterol	N/A	85.8 ± 1.65	180	Oral	Favorable release profile in the gastrointestinal fluids.	[34]
Sorbitan monostearate and cholesterol	N/A	40	100	Oral	The nanoformulation presents a high stability in neutral pH and enhances the cellular permeability in caco-2 cell monolayer.	[35]
Cholesterol, phosphatidylcholine, and Tween-80	60.21 ± 1.59	N/A	126.7 ± 4.3	N/A	Enhancing synergistic effects between EGCG and paclitaxel in inducing apoptosis in MDA-MB-231 breast cancer cells.	[36]